- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2009
- Public Summary Document (PSD) November 2009 PBAC Meeting - PDF
Dabigatran etexilate mesilate – November 2009
Dabigatran etexilate mesilate, capsules, 75 mg and 110 mg (base), Pradaxa®, November 2009
Last updated
5 March 2010